ClinicalTrials.gov
public full text
Public Domain
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
Primary Objective: * To confirm if ketoconazole inhibition of CYP3A activity affects fractional excretion of docetaxel in the urine. Secondary Objective: * To compare the metabolite ratios of the major metabolites of docetaxel in the presence and absence of CYP3A inhibition.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Using Phenazopyridine for In-office Cystoscopy#811239
- Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome#825399
- Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction#887475
- Moving beyond oral gavage: micropipette-guided drug administration (MDA) as a 3R refinement for voluntary oral drug delivery in rodents#266540
- Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter Urinary Tract Infections.#127651
Record · ID 891457
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive